Lucid Scientific has filed a notice of an exempt offering of securities to raise $9,164,494.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Lucid Scientific is raising $9,164,494.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Samuel Inman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Lucid Scientific
Lucid Scientific designs and develops the RESIPHER series of real-time cellular activity monitors. The world’s first handheld cell culture monitor to measure oxygen consumption in standard multi-well plates, providing continuous insight directly from your incubator. Resipher continuously monitors cell culture oxygen consumption inside the incubator. Data is streamed real-time to the cloud so you and your team can view on any connected device. An array of ultra-sensitive dissolved oxygen sensors developed by Lucid performs dynamic vertical micro-movements that scan oxygen gradients formed by metabolically active cells. Resipher provides researchers never-before-seen insights into dynamic cellular responses. High resolution gradient data for each well provides more in-depth analysis.
To learn more about Lucid Scientific, visit http://lucidsci.com/
Contact:
Samuel Inman, President and Chief Executive Officer
617-237-0665
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.